Build Your Comparison

Side-by-side financial analysis
TCI logo
TCI
ARL logo
ARL
JPM logo
JPM
NHI logo
NHI
NXRT logo
NXRT
Try popular comparisons:

Stock Comparison

TCI vs ARL vs JPM vs NHI vs NXRT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TCI
Transcontinental Realty Investors, Inc.

Real Estate - Services

Real EstateNYSE • US
Market Cap$339M
5Y Perf.+30.9%
ARL
American Realty Investors, Inc.

Real Estate - Development

Real EstateNYSE • US
Market Cap$258M
5Y Perf.+78.0%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$908.57B
5Y Perf.+245.8%
NHI
National Health Investors, Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$3.43B
5Y Perf.+16.6%
NXRT
NexPoint Residential Trust, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$684M
5Y Perf.-23.7%

TCI vs ARL vs JPM vs NHI vs NXRT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TCI logoTCI
ARL logoARL
JPM logoJPM
NHI logoNHI
NXRT logoNXRT
IndustryReal Estate - ServicesReal Estate - DevelopmentBanks - DiversifiedREIT - Healthcare FacilitiesREIT - Residential
Market Cap$339M$258M$908.57B$3.43B$684M
Revenue (TTM)$49M$50M$280.33B$403M$252M
Net Income (TTM)$9M$12M$57.05B$148M$-32M
Gross Margin-38.7%-19.6%60.0%61.3%91.1%
Operating Margin-10.3%-15.5%25.9%48.5%11.5%
Forward P/E24.6x0.8x14.6x19.9x
Total Debt$211M$214M$942.38B$1.16B$1.56B
Cash & Equiv.$14M$14M$343.34B$20M$14M

TCI vs ARL vs JPM vs NHI vs NXRTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TCI
ARL
JPM
NHI
NXRT
StockJun 20Jun 26Return
Transcontinental Re… (TCI)100130.9+30.9%
American Realty Inv… (ARL)100178.0+78.0%
JPMorgan Chase & Co. (JPM)100345.8+245.8%
National Health Inv… (NHI)100116.6+16.6%
NexPoint Residentia… (NXRT)10076.3-23.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: TCI vs ARL vs JPM vs NHI vs NXRT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NHI leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. JPMorgan Chase & Co. is the stronger pick specifically for dividend income and shareholder returns and recent price momentum and sentiment. TCI and ARL also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇NHI emerged as the overall leader. Track its performance:
TCI
Transcontinental Realty Investors, Inc.
The Real Estate Income Play

TCI ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.

  • Rev growth 9.6%, EPS growth 135.3%, 3Y rev CAGR 12.9%
  • Lower volatility, beta 0.47, Low D/E 24.3%, current ratio 9.49x
  • Beta 0.47 vs ARL's 1.00, lower leverage
Best for: growth exposure and sleep-well-at-night
ARL
American Realty Investors, Inc.
The Real Estate Income Play

ARL is the clearest fit if your priority is valuation efficiency.

  • PEG 0.07 vs TCI's 1.56
  • Lower P/E (0.8x vs 19.9x)
Best for: valuation efficiency
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the #2 pick in this set and the best alternative if long-term compounding is your priority.

  • 481.2% 10Y total return vs ARL's 192.0%
  • 1.8% yield, 15-year raise streak, vs NXRT's 7.8%, (2 stocks pay no dividend)
  • +20.9% vs NXRT's -12.7%
Best for: long-term compounding
NHI
National Health Investors, Inc.
The Real Estate Income Play

NHI carries the broadest edge in this set and is the clearest fit for growth and quality.

  • 12.9% FFO/revenue growth vs NXRT's -3.2%
  • 36.8% margin vs NXRT's -12.7%
  • 5.4% ROA vs NXRT's -1.7%, ROIC 5.6% vs 1.1%
Best for: growth and quality
NXRT
NexPoint Residential Trust, Inc.
The Real Estate Income Play

NXRT is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 11 yrs, beta 0.49, yield 7.8%
  • Beta 0.49, yield 7.8%, current ratio 0.48x
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthNHI logoNHI12.9% FFO/revenue growth vs NXRT's -3.2%
ValueARL logoARLLower P/E (0.8x vs 19.9x)
Quality / MarginsNHI logoNHI36.8% margin vs NXRT's -12.7%
Stability / SafetyTCI logoTCIBeta 0.47 vs ARL's 1.00, lower leverage
DividendsJPM logoJPM1.8% yield, 15-year raise streak, vs NXRT's 7.8%, (2 stocks pay no dividend)
Momentum (1Y)JPM logoJPM+20.9% vs NXRT's -12.7%
Efficiency (ROA)NHI logoNHI5.4% ROA vs NXRT's -1.7%, ROIC 5.6% vs 1.1%

TCI vs ARL vs JPM vs NHI vs NXRT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

TCITranscontinental Realty Investors, Inc.
FY 2025
Residential Segment
69.6%$34M
CommercialSegmentsMember
30.4%$15M
ARLAmerican Realty Investors, Inc.
FY 2025
Residential Segment
69.6%$34M
Commercial Segments
30.4%$15M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
NHINational Health Investors, Inc.
FY 2025
Real Estate Investment Segment
78.7%$296M
Senior Housing Operating Portfolio
21.3%$80M
NXRTNexPoint Residential Trust, Inc.

Segment breakdown not available.

TCI vs ARL vs JPM vs NHI vs NXRT — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLTCILAGGINGARL

Income & Cash Flow (Last 12 Months)

NHI leads this category, winning 4 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 5675.6x TCI's $49M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to NXRT's -12.7%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTCI logoTCITranscontinental …ARL logoARLAmerican Realty I…JPM logoJPMJPMorgan Chase & …NHI logoNHINational Health I…NXRT logoNXRTNexPoint Resident…
RevenueTrailing 12 months$49M$50M$280.3B$403M$252M
EBITDAEarnings before interest/tax$8M$5M$81.4B$282M$125M
Net IncomeAfter-tax profit$9M$12M$57.0B$148M-$32M
Free Cash FlowCash after capex-$51M$2M$100.9B$226M$79M
Gross MarginGross profit ÷ Revenue-38.7%-19.6%+60.0%+61.3%+91.1%
Operating MarginEBIT ÷ Revenue-10.3%-15.5%+25.9%+48.5%+11.5%
Net MarginNet income ÷ Revenue+18.9%+24.2%+20.4%+36.8%-12.7%
FCF MarginFCF ÷ Revenue-104.2%+3.7%+36.0%+56.1%+31.2%
Rev. Growth (YoY)Latest quarter vs prior year+2.8%+2.8%+29.7%+0.5%
EPS Growth (YoY)Latest quarter vs prior year-96.2%-116.7%+16.0%+10.8%0.0%
NHI leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

NXRT leads this category, winning 3 of 7 comparable metrics.

At 16.2x trailing earnings, JPM trades at a 34% valuation discount to TCI's 24.6x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.92x vs TCI's 1.56x — a lower PEG means you pay less per unit of expected earnings growth.

MetricTCI logoTCITranscontinental …ARL logoARLAmerican Realty I…JPM logoJPMJPMorgan Chase & …NHI logoNHINational Health I…NXRT logoNXRTNexPoint Resident…
Market CapShares × price$339M$258M$908.6B$3.4B$684M
Enterprise ValueMkt cap + debt − cash$536M$459M$1.51T$4.6B$2.2B
Trailing P/EPrice ÷ TTM EPS24.56x16.49x16.22x23.45x-21.40x
Forward P/EPrice ÷ next-FY EPS est.0.76x14.60x19.90x
PEG RatioP/E ÷ EPS growth rate1.56x1.42x0.92x
EV / EBITDAEnterprise value multiple86.02x74.60x18.52x16.42x18.02x
Price / SalesMarket cap ÷ Revenue6.92x5.17x3.25x9.07x2.72x
Price / BookPrice ÷ Book value/share0.39x0.32x2.51x2.16x2.28x
Price / FCFMarket cap ÷ FCF9.01x15.58x8.19x
NXRT leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

TCI leads this category, winning 4 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-10 for NXRT. TCI carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs ARL's 3/9, reflecting solid financial health.

MetricTCI logoTCITranscontinental …ARL logoARLAmerican Realty I…JPM logoJPMJPMorgan Chase & …NHI logoNHINational Health I…NXRT logoNXRTNexPoint Resident…
ROE (TTM)Return on equity+1.1%+1.5%+15.9%+9.8%-10.1%
ROA (TTM)Return on assets+0.8%+1.1%+1.3%+5.4%-1.7%
ROICReturn on invested capital-0.5%-0.5%+4.5%+5.6%+1.1%
ROCEReturn on capital employed-0.6%-0.6%+8.9%+8.0%+1.5%
Piotroski ScoreFundamental quality 0–943564
Debt / EquityFinancial leverage0.24x0.26x2.60x0.76x5.18x
Net DebtTotal debt minus cash$197M$200M$599.0B$1.1B$1.5B
Cash & Equiv.Liquid assets$14M$14M$343.3B$20M$14M
Total DebtShort + long-term debt$211M$214M$942.4B$1.2B$1.6B
Interest CoverageEBIT ÷ Interest expense4.22x4.11x0.74x3.45x0.47x
TCI leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $6,566 for NXRT. Over the past 12 months, JPM leads with a +20.9% total return vs NXRT's -12.7%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs NXRT's -10.6% — a key indicator of consistent wealth creation.

MetricTCI logoTCITranscontinental …ARL logoARLAmerican Realty I…JPM logoJPMJPMorgan Chase & …NHI logoNHINational Health I…NXRT logoNXRTNexPoint Resident…
YTD ReturnYear-to-date-33.3%-1.5%+0.8%-6.6%-5.2%
1-Year ReturnPast 12 months-3.1%+5.0%+20.9%+5.1%-12.7%
3-Year ReturnCumulative with dividends+3.4%-23.2%+138.8%+52.9%-28.6%
5-Year ReturnCumulative with dividends+27.4%+51.5%+135.5%+36.4%-34.3%
10-Year ReturnCumulative with dividends+331.8%+192.0%+481.2%+53.0%+144.1%
CAGR (3Y)Annualised 3-year return+1.1%-8.4%+33.7%+15.2%-10.6%
JPM leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — JPM and NHI each lead in 1 of 2 comparable metrics.

NHI is the less volatile stock with a -0.21 beta — it tends to amplify market swings less than ARL's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs TCI's 65.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTCI logoTCITranscontinental …ARL logoARLAmerican Realty I…JPM logoJPMJPMorgan Chase & …NHI logoNHINational Health I…NXRT logoNXRTNexPoint Resident…
Beta (5Y)Sensitivity to S&P 5000.47x1.00x0.87x-0.21x0.49x
52-Week HighHighest price in past year$59.65$20.00$338.09$90.94$35.08
52-Week LowLowest price in past year$31.48$12.42$269.72$67.94$23.79
% of 52W HighCurrent price vs 52-week peak+65.9%+80.0%+96.2%+77.9%+76.9%
RSI (14)Momentum oscillator 0–10045.652.272.140.532.7
Avg Volume (50D)Average daily shares traded4K6K7.4M366K181K
Evenly matched — JPM and NHI each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — JPM and NXRT each lead in 1 of 2 comparable metrics.

Analyst consensus: JPM as "Buy", NHI as "Hold", NXRT as "Hold". Consensus price targets imply 17.8% upside for NHI (target: $83) vs 0.1% for NXRT (target: $27). For income investors, NXRT offers the higher dividend yield at 7.82% vs JPM's 1.83%.

MetricTCI logoTCITranscontinental …ARL logoARLAmerican Realty I…JPM logoJPMJPMorgan Chase & …NHI logoNHINational Health I…NXRT logoNXRTNexPoint Resident…
Analyst RatingConsensus buy/hold/sellBuyHoldHold
Price TargetConsensus 12-month target$339.75$83.40$27.00
# AnalystsCovering analysts611810
Dividend YieldAnnual dividend ÷ price+1.8%+5.1%+7.8%
Dividend StreakConsecutive years of raises1015111
Dividend / ShareAnnual DPS$5.95$3.61$2.11
Buyback YieldShare repurchases ÷ mkt cap+0.3%+0.4%+3.8%0.0%+1.1%
Evenly matched — JPM and NXRT each lead in 1 of 2 comparable metrics.
Key Takeaway

NHI leads in 1 of 6 categories (Income & Cash Flow). NXRT leads in 1 (Valuation Metrics). 2 tied.

Best OverallTranscontinental Realty Inv… (TCI)Leads 1 of 6 categories
Loading custom metrics...

TCI vs ARL vs JPM vs NHI vs NXRT: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is TCI or ARL or JPM or NHI or NXRT a better buy right now?

For growth investors, National Health Investors, Inc.

(NHI) is the stronger pick with 12. 9% revenue growth year-over-year, versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TCI or ARL or JPM or NHI or NXRT?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 2x versus Transcontinental Realty Investors, Inc. at 24. 6x. On forward P/E, American Realty Investors, Inc. is actually cheaper at 0. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: American Realty Investors, Inc. wins at 0. 07x versus JPMorgan Chase & Co. 's 0. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — TCI or ARL or JPM or NHI or NXRT?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +135. 5%, compared to -34. 3% for NexPoint Residential Trust, Inc. (NXRT). Over 10 years, the gap is even starker: JPM returned +481. 2% versus NHI's +53. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TCI or ARL or JPM or NHI or NXRT?

By beta (market sensitivity over 5 years), National Health Investors, Inc.

(NHI) is the lower-risk stock at -0. 21β versus American Realty Investors, Inc. 's 1. 00β — meaning ARL is approximately -574% more volatile than NHI relative to the S&P 500. On balance sheet safety, Transcontinental Realty Investors, Inc. (TCI) carries a lower debt/equity ratio of 24% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — TCI or ARL or JPM or NHI or NXRT?

By revenue growth (latest reported year), National Health Investors, Inc.

(NHI) is pulling ahead at 12. 9% versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). On earnings-per-share growth, the picture is similar: American Realty Investors, Inc. grew EPS 206. 6% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, TCI leads at 12. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TCI or ARL or JPM or NHI or NXRT?

National Health Investors, Inc.

(NHI) is the more profitable company, earning 37. 6% net margin versus -12. 7% for NexPoint Residential Trust, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus -12. 9% for TCI. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TCI or ARL or JPM or NHI or NXRT more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, American Realty Investors, Inc. (ARL) is the more undervalued stock at a PEG of 0. 07x versus JPMorgan Chase & Co. 's 0. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, American Realty Investors, Inc. (ARL) trades at 0. 8x forward P/E versus 19. 9x for National Health Investors, Inc. — 19. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 17. 8% to $83. 40.

08

Which pays a better dividend — TCI or ARL or JPM or NHI or NXRT?

In this comparison, NXRT (7.

8% yield), NHI (5. 1% yield), JPM (1. 8% yield) pay a dividend. TCI, ARL do not pay a meaningful dividend and should not be held primarily for income.

09

Is TCI or ARL or JPM or NHI or NXRT better for a retirement portfolio?

For long-horizon retirement investors, National Health Investors, Inc.

(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 21), 5. 1% yield). Both have compounded well over 10 years (NHI: +53. 0%, ARL: +192. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TCI and ARL and JPM and NHI and NXRT?

These companies operate in different sectors (TCI (Real Estate) and ARL (Real Estate) and JPM (Financial Services) and NHI (Real Estate) and NXRT (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: TCI is a small-cap quality compounder stock; ARL is a small-cap deep-value stock; JPM is a large-cap deep-value stock; NHI is a small-cap income-oriented stock; NXRT is a small-cap income-oriented stock. JPM, NHI, NXRT pay a dividend while TCI, ARL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.